To investigate whether Ad-AS-TK/GCV could exhibit enhanced apoptotic effects in BP-CML cells, the Ad transduced cells, treated with 100 μmol/l GCV for an additional 48 h, were assayed with Annexin V PE. This evidence concerns the gene TKT and chronic myelogenous leukemia, BCR-ABL1 positive.